Physician profile
James R Taylor
NPI 1083722896
$9,143.81
in general payments reported to CMS, 2019-2025
12 companies · $3,379 in 2025
The $3,379 reported for 2025 was more than what 76% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,904 · 2020: $21.70 · 2021: $21.13 · 2022: $14.35 · 2023: $668 · 2024: $136 · 2025: $3,379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,193 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $548 · Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,193.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $548.00 |
| Food and Beverage | $441.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,500.00 | 2019 | |
| Biogen, INC. | $3,741.00 | 2023-2025 | |
| Atricure, INC. | $267.32 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Medtronic Vascular, INC. | $143.35 | 2019-2020 | |
| Edwards Lifesciences Corporation | $142.84 | 2022-2025 | Mitris Resilia Mitral Valve |
| Astrazeneca Pharmaceuticals LP | $135.00 | 2019 | |
| Medtronic, INC. | $61.50 | 2021-2025 | Corevalve Evolut R |
| Smith+Nephew, INC. | $45.83 | 2023 | Pico 7 |
| Bolton Medical INC | $39.94 | 2025 | Thoraflex Hybrid |
| Abbott Laboratories | $22.49 | 2023 | Mitraclip |
| Lsi Solutions INC | $22.39 | 2019 | |
| Pfizer INC. | $22.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.